CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review.
about
Inertial microfluidics for sheath-less high-throughput flow cytometryFetal immunodeficiency: a consequence of placental insufficiencyUse of formalin-fixed, propidium iodide-stained human leukocytes as a standard for enumerating CD4+ T lymphocytes in a single-platform assayDistribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic localesLab-on-chip cytometry based on magnetoresistive sensors for bacteria detection in milkMicrofluidic sample preparation for diagnostic cytopathologyHIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.Biochemical and haematological changes in HIV subjects receiving winniecure antiretroviral drug in NigeriaImmunohematological reference ranges for adult Ethiopians.A five-year longitudinal analysis of sooty mangabeys naturally infected with simian immunodeficiency virus reveals a slow but progressive decline in CD4+ T-cell count whose magnitude is not predicted by viral load or immune activationCellometer vision as an alternative to flow cytometry for cell cycle analysis, mitochondrial potential, and immunophenotyping.CD4+ lymphocyte values and trends in individuals infected with human immunodeficiency virus and/or co-infected with hepatitis C virus in the Gambia.Population pharmacokinetics and pharmacodynamic modeling of abacavir (1592U89) from a dose-ranging, double-blind, randomized monotherapy trial with human immunodeficiency virus-infected subjects.Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisAbsolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression.Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trialViral load as a surrogate end point in HIV disease.Clinical and immunological status of a newly diagnosed HIV positive population, in Marrakech, Morocco.Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two EpidemicsImmunohematological reference ranges for adults from the Central African RepublicA review on peripheral blood CD4+ T lymphocyte counts in healthy adult IndiansPredicting AIDS-related events using CD4 percentage or CD4 absolute countsTime to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in GhanaHematological reference ranges among healthy UgandansPredictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug usersDidanosine.Current status of HIV therapy: I. Antiretroviral agents.Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studiesClinic Network Collaboration and Patient Tracing to Maximize Retention in HIV CareClinical profile of human immunodeficiency virus patients with opportunistic infections: A descriptive case series study.Antiretroviral therapy for patients with HIV diseaseImmunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.The HIV RNA setpoint theory revisited.Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infectionShort communication: factors influencing time to CD4(+) T cell counts >200 cells/mm(3) in HIV-infected individuals with CD4(+) T cell <50 cells/mm(3) at the time of starting combination antiretroviral therapyCaring for patients with HIV infection. Management plan for family physicians.Enteric pathogens in HIV-positive patients with diarrhoea and their correlation with CD4+ T-lymphocyte countsComplete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.Estimating patterns of CD4 lymphocyte decline using data from a prevalent cohort of HIV infected individuals.
P2860
Q23909733-06B78BD5-BFFF-49F1-A8A7-56F6A2FE3065Q28256948-0740B5B4-7992-4580-BE0B-07525B9B3201Q28359812-AEB8DC3D-67A9-432B-98EE-7F9E10DFAD8BQ28362961-F4263F7C-68E8-4D5A-A09C-A32DAFB818CEQ30429361-276F1539-983F-4EA5-9DE4-330C2E5A885BQ30437375-D78738D5-C5D4-4631-99D3-7BC29492C197Q33280133-C7A1F23C-27AB-4960-A2D6-A115D431625AQ33410774-2C8D4198-3FE3-42DC-8FC8-18408C241A81Q33637326-F42D1942-3DC9-40A0-A314-6CA95C22F00EQ33877335-9096230B-0E58-46A3-8D81-52CCEB7BC216Q33888434-0D1081E6-7179-4481-ACEC-3C7B5B5D9935Q33918688-EE4D2BA2-F5CD-4700-BD35-2BE048765FF1Q33980164-D82905B2-0401-4518-8E9A-5E97F410040EQ33998304-F28DBE01-B27D-4F24-AB8D-1DF67B7ED08CQ34010283-A26D3346-0EBB-4557-A993-9AFE41670716Q34076185-1D87B567-F5B2-4443-82FD-8DFB2001FE19Q34408313-92D8409D-FA3C-4742-B898-1F26A12D6D97Q34533854-CA2F1E85-DB3C-4C53-B744-3EF461427836Q34643029-3341245A-D413-4BEA-A42B-5234207AED59Q34734797-DCC9E973-61F8-490B-BD27-C1E06ECFCD94Q34995895-6D6D8F4A-554E-465D-8510-E7D9F12D9758Q35008567-2301C608-F113-430B-A698-A15C351D5CBBQ35040103-81491F05-B78C-4842-B9A3-B51C99510EFDQ35071036-AA61BA8D-70C7-4134-BE4F-217DC5F5DB0EQ35224306-214859F8-A925-4266-A619-511F78511CE0Q35225429-BE786572-59D9-4370-A08E-892E527F5B4BQ35255870-EEA62B39-82F6-45F0-8C37-7FF5EEFEEFC0Q35335827-B594F4EE-D420-4B69-804B-F47107AADE9AQ35542370-F64E562D-1160-4BE2-B486-FBC38E744EC5Q35641804-B6816803-507D-4C91-A156-3BEFC8714667Q35686801-5A39C519-C2F4-489D-B517-9452DF109375Q35802185-1B3BECE6-85AE-41C2-A58D-CB18CBD47B22Q35920633-64DB157C-4385-4EF8-84B7-88980FFD756BQ36391740-DDC09E6C-521C-4D01-9BA1-2AE6CE648CCFQ36410953-031318C5-592A-44D7-8B4A-6CA4CC6001FDQ36419507-E4AB83F5-8DEB-4DC3-9C98-1DD57D157866Q36652796-21A08291-37D2-4335-A59B-89C83358AAEBQ36671714-2A724AF7-9075-4638-84E5-2D5A4C61D17BQ36685254-E372C021-F82E-474A-9EEF-AA01F7CA0A9CQ36722238-1F0F64CB-75F0-44B2-8328-A1E586E54760
P2860
CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review.
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
CD4+ lymphocyte cell enumerati ...... iency virus disease: a review.
@ast
CD4+ lymphocyte cell enumerati ...... iency virus disease: a review.
@en
type
label
CD4+ lymphocyte cell enumerati ...... iency virus disease: a review.
@ast
CD4+ lymphocyte cell enumerati ...... iency virus disease: a review.
@en
prefLabel
CD4+ lymphocyte cell enumerati ...... iency virus disease: a review.
@ast
CD4+ lymphocyte cell enumerati ...... iency virus disease: a review.
@en
P356
P1476
CD4+ lymphocyte cell enumerati ...... iency virus disease: a review.
@en
P2093
P304
P356
10.1093/INFDIS/165.2.352
P407
P50
P577
1992-02-01T00:00:00Z